Trial · NCT02107196
Participant flow20
How many started, completed or left each group, period by period.
1 to 20 of 20
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| 12-week Treatment Period | STARTED | Ibodutant 10 mg | 271 | |
| 12-week Treatment Period | STARTED | Placebo | 264 | |
| 12-week Treatment Period | Intention To Treat (ITT) | Ibodutant 10 mg | 271 | |
| 12-week Treatment Period | Intention To Treat (ITT) | Placebo | 264 | |
| 12-week Treatment Period | Modified ITT | Ibodutant 10 mg | 221 | |
| 12-week Treatment Period | Modified ITT | Placebo | 216 | |
| 12-week Treatment Period | COMPLETED | Ibodutant 10 mg | 227 | |
| 12-week Treatment Period | COMPLETED | Placebo | 225 | |
| 12-week Treatment Period | NOT COMPLETED | Ibodutant 10 mg | 44 | |
| 12-week Treatment Period | NOT COMPLETED | Placebo | 39 | |
| 4-week Randomized Withdrawal (RW) Period | STARTED | Ibodutant 10 mg | 338 | |
| 4-week Randomized Withdrawal (RW) Period | STARTED | Placebo | 114 | |
| 4-week Randomized Withdrawal (RW) Period | RW Population | Ibodutant 10 mg | 338 | |
| 4-week Randomized Withdrawal (RW) Period | RW Population | Placebo | 114 | |
| 4-week Randomized Withdrawal (RW) Period | Modified RW Population | Ibodutant 10 mg | 272 | |
| 4-week Randomized Withdrawal (RW) Period | Modified RW Population | Placebo | 90 | |
| 4-week Randomized Withdrawal (RW) Period | COMPLETED | Ibodutant 10 mg | 315 | |
| 4-week Randomized Withdrawal (RW) Period | COMPLETED | Placebo | 109 | |
| 4-week Randomized Withdrawal (RW) Period | NOT COMPLETED | Ibodutant 10 mg | 23 | |
| 4-week Randomized Withdrawal (RW) Period | NOT COMPLETED | Placebo | 5 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02107196/flow